Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Strazzabosco

Showing results (31-40 of 177) with videos related to

Pageof 18
Sort By:
Current Oncology Reports|October 18, 2022
Locoregional Therapy in the Management of Intrahepatic Cholangiocarcinoma: Is There Sufficient Evidence to Guide Current Clinical Practice?Yifan Wang, Mario Strazzabosco, David C Madoff
Advances in Cancer Research|February 13, 2021
Intrahepatic cholangiocarcinoma: Morpho-molecular pathology, tumor reactive microenvironment, and malignant progressionAlphonse E Sirica, Mario Strazzabosco, Massimiliano Cadamuro
Hepatology (Baltimore, Md.)|May 25, 2013
Nonsteroidal anti-inflammatory drug use, chronic liver disease, and hepatocellular carcinoma: the egg of columbus or another illusion?Amy K Kim, James Dziura, Mario Strazzabosco
Clinical Colorectal Cancer|July 25, 2008
Incidence and management of colorectal cancer in liver transplant recipientsTaiga Nishihori, Mario Strazzabosco, Muhammad Wasif Saif
World Journal of Hepatology|April 12, 2017
Tumor reactive stroma in cholangiocarcinoma: The fuel behind cancer aggressivenessSimone Brivio, Massimiliano Cadamuro, Mario Strazzabosco, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|August 27, 2025
From hierarchy to conversion: A watermill approach to the therapeutic management of patients with hepatocellular carcinomaEdoardo G Giannini, Jean-François Dufour, Mario Strazzabosco
Clinics in Liver Disease|June 22, 2011
Systemic therapy in hepatocellular carcinomaStephen H Wrzesinski, Tamar H Taddei, Mario Strazzabosco
Digestive Diseases (Basel, Switzerland)|December 8, 2015
Malignancies in Primary Sclerosing Cholangitis--A Continuing ThreatGiulia Bonato, Laura Cristoferi, Mario Strazzabosco, et al.
Hepatology (Baltimore, Md.)|January 11, 2017
Value-based care in hepatologyMario Strazzabosco, John I Allen, Elizabeth O Teisberg
Journal of Clinical Medicine|December 26, 2015
Epithelial-to-Mesenchymal Transition and Cancer Invasiveness: What Can We Learn from Cholangiocarcinoma?Simone Brivio, Massimiliano Cadamuro, Luca Fabris, et al.
Pageof 18

Showing results (31-40 of 177) with videos related to

Sort By:
Pageof 18
Current Oncology Reports|October 18, 2022
Locoregional Therapy in the Management of Intrahepatic Cholangiocarcinoma: Is There Sufficient Evidence to Guide Current Clinical Practice?Yifan Wang, Mario Strazzabosco, David C Madoff
Advances in Cancer Research|February 13, 2021
Intrahepatic cholangiocarcinoma: Morpho-molecular pathology, tumor reactive microenvironment, and malignant progressionAlphonse E Sirica, Mario Strazzabosco, Massimiliano Cadamuro
Hepatology (Baltimore, Md.)|May 25, 2013
Nonsteroidal anti-inflammatory drug use, chronic liver disease, and hepatocellular carcinoma: the egg of columbus or another illusion?Amy K Kim, James Dziura, Mario Strazzabosco
Clinical Colorectal Cancer|July 25, 2008
Incidence and management of colorectal cancer in liver transplant recipientsTaiga Nishihori, Mario Strazzabosco, Muhammad Wasif Saif
World Journal of Hepatology|April 12, 2017
Tumor reactive stroma in cholangiocarcinoma: The fuel behind cancer aggressivenessSimone Brivio, Massimiliano Cadamuro, Mario Strazzabosco, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|August 27, 2025
From hierarchy to conversion: A watermill approach to the therapeutic management of patients with hepatocellular carcinomaEdoardo G Giannini, Jean-François Dufour, Mario Strazzabosco
Clinics in Liver Disease|June 22, 2011
Systemic therapy in hepatocellular carcinomaStephen H Wrzesinski, Tamar H Taddei, Mario Strazzabosco
Digestive Diseases (Basel, Switzerland)|December 8, 2015
Malignancies in Primary Sclerosing Cholangitis--A Continuing ThreatGiulia Bonato, Laura Cristoferi, Mario Strazzabosco, et al.
Hepatology (Baltimore, Md.)|January 11, 2017
Value-based care in hepatologyMario Strazzabosco, John I Allen, Elizabeth O Teisberg
Journal of Clinical Medicine|December 26, 2015
Epithelial-to-Mesenchymal Transition and Cancer Invasiveness: What Can We Learn from Cholangiocarcinoma?Simone Brivio, Massimiliano Cadamuro, Luca Fabris, et al.
Pageof 18